Schroder Investment Management Group Increases Holdings in McKesson Corporation $MCK

Schroder Investment Management Group boosted its stake in shares of McKesson Corporation (NYSE:MCK) by 4.2% in the 3rd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 153,087 shares of the company’s stock after acquiring an additional 6,213 shares during the period. Schroder Investment Management Group owned 0.12% of McKesson worth $118,266,000 at the end of the most recent quarter.

Several other institutional investors have also added to or reduced their stakes in the company. J.W. Cole Advisors Inc. lifted its position in McKesson by 35.3% during the third quarter. J.W. Cole Advisors Inc. now owns 5,089 shares of the company’s stock valued at $3,931,000 after acquiring an additional 1,329 shares during the last quarter. Private Wealth Partners LLC increased its holdings in shares of McKesson by 5.6% in the third quarter. Private Wealth Partners LLC now owns 31,841 shares of the company’s stock valued at $24,598,000 after purchasing an additional 1,682 shares during the period. AlphaQuest LLC increased its holdings in McKesson by 91.2% in the 3rd quarter. AlphaQuest LLC now owns 1,767 shares of the company’s stock worth $1,365,000 after buying an additional 843 shares during the period. CW Advisors LLC raised its holdings in shares of McKesson by 282.5% during the second quarter. CW Advisors LLC now owns 11,008 shares of the company’s stock worth $8,067,000 after purchasing an additional 8,130 shares during the last quarter. Finally, Envestnet Asset Management Inc. lifted its holdings in shares of McKesson by 12.4% in the 3rd quarter. Envestnet Asset Management Inc. now owns 330,647 shares of the company’s stock valued at $255,438,000 after buying an additional 36,451 shares during the period. Hedge funds and other institutional investors own 85.07% of the company’s stock.

Wall Street Analysts Forecast Growth

Several brokerages recently weighed in on MCK. Wells Fargo & Company lifted their price target on McKesson from $914.00 to $925.00 and gave the company an “equal weight” rating in a research note on Thursday, February 5th. Weiss Ratings lowered shares of McKesson from a “buy (a-)” rating to a “buy (b+)” rating in a research note on Thursday, February 5th. Raymond James Financial set a $970.00 price objective on shares of McKesson in a research report on Thursday. TD Cowen raised their price objective on McKesson from $1,000.00 to $1,012.00 and gave the stock a “buy” rating in a research report on Thursday, February 5th. Finally, JPMorgan Chase & Co. upped their price target on McKesson from $983.00 to $1,107.00 and gave the stock an “overweight” rating in a research note on Tuesday, February 10th. Thirteen analysts have rated the stock with a Buy rating and four have given a Hold rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $960.93.

Insider Activity

In related news, CAO Napoleon B. Rutledge, Jr. sold 328 shares of the firm’s stock in a transaction that occurred on Friday, February 6th. The shares were sold at an average price of $955.00, for a total value of $313,240.00. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, EVP Michele Lau sold 2,725 shares of the company’s stock in a transaction dated Monday, March 2nd. The stock was sold at an average price of $990.00, for a total value of $2,697,750.00. Following the sale, the executive vice president owned 3,247 shares of the company’s stock, valued at $3,214,530. This represents a 45.63% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold a total of 3,868 shares of company stock valued at $3,743,820 in the last three months. Company insiders own 0.08% of the company’s stock.

McKesson Stock Performance

NYSE MCK opened at $941.19 on Tuesday. The firm has a market cap of $115.29 billion, a PE ratio of 27.07, a P/E/G ratio of 1.48 and a beta of 0.38. The firm’s fifty day moving average is $884.77 and its two-hundred day moving average is $819.18. McKesson Corporation has a one year low of $633.53 and a one year high of $999.00.

McKesson (NYSE:MCK) last announced its quarterly earnings data on Wednesday, February 4th. The company reported $9.34 earnings per share for the quarter, beating analysts’ consensus estimates of $9.19 by $0.15. McKesson had a negative return on equity of 338.97% and a net margin of 1.09%.The company had revenue of $106.16 billion for the quarter, compared to analyst estimates of $105.98 billion. During the same quarter in the previous year, the company earned $8.03 EPS. The firm’s revenue for the quarter was up 11.4% compared to the same quarter last year. McKesson has set its FY 2026 guidance at 38.800-39.200 EPS. Research analysts predict that McKesson Corporation will post 32.77 earnings per share for the current year.

McKesson Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, April 1st. Shareholders of record on Monday, March 2nd will be issued a $0.82 dividend. The ex-dividend date is Monday, March 2nd. This represents a $3.28 annualized dividend and a yield of 0.3%. McKesson’s payout ratio is 9.43%.

About McKesson

McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.